2022
DOI: 10.1002/exp.20210082
|View full text |Cite
|
Sign up to set email alerts
|

Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic

Abstract: Coronavirus disease 2019 (COVID‐19) continually poses a significant threat to the human race, and prophylactic vaccination is the most potent approach to end this pandemic. Nanotechnology is widely adopted during COVID‐19 vaccine development, and the engineering of nanostructured materials such as nanoparticles has opened new possibilities in innovative vaccine development by improving the design and accelerating the development process. This review aims to comprehensively understand the current situation and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(21 citation statements)
references
References 168 publications
0
21
0
Order By: Relevance
“…They also enhance the uptake by antigen-presenting cells. Lipids are known as an excellent transporter of nucleic acids to the cells, mainly due to their compatibility with the lipid cell membranes [ 154 ]. Although mRNA-based vaccines have never been approved, the nucleoside-modified mRNA-lipid nanoparticles (LNP) vaccine platform employed by Pfizer/BioNTech and Moderna in developing SARS-CoV-2 vaccines has extensively undergone preclinical studies for its effectiveness and supportive protective effect of the humoral immune responses [ 155 ].…”
Section: Future Perspectivementioning
confidence: 99%
“…They also enhance the uptake by antigen-presenting cells. Lipids are known as an excellent transporter of nucleic acids to the cells, mainly due to their compatibility with the lipid cell membranes [ 154 ]. Although mRNA-based vaccines have never been approved, the nucleoside-modified mRNA-lipid nanoparticles (LNP) vaccine platform employed by Pfizer/BioNTech and Moderna in developing SARS-CoV-2 vaccines has extensively undergone preclinical studies for its effectiveness and supportive protective effect of the humoral immune responses [ 155 ].…”
Section: Future Perspectivementioning
confidence: 99%
“…For a long period, alum adjuvant which creates a depot at the injection site was used to protect antigens and enable their prolonged exposure to activate innate cell immunity. Nanoparticles are now used as vaccine carriers, resulting in more effective vaccine delivery and antigen uptake by DC [39]. Particularly used in the context of mRNA vaccines, nanotechnologies have led to innovative and faster vaccine development that demonstrated a high efficiency [39][40][41][42].…”
Section: Taa-based Therapeutic Cancer Vaccines: Disappointments and P...mentioning
confidence: 99%
“…Nanoparticles are now used as vaccine carriers, resulting in more effective vaccine delivery and antigen uptake by DC [39]. Particularly used in the context of mRNA vaccines, nanotechnologies have led to innovative and faster vaccine development that demonstrated a high efficiency [39][40][41][42]. Recently, a novel broad-spectrum neoantigen vaccine delivery system based on β-1,3-glucan particles and derived from natural edible Saccharomyces cerevisiae showed strong activation of immune cells that inhibited tumor growth in various syngeneic mouse models [43].…”
Section: Taa-based Therapeutic Cancer Vaccines: Disappointments and P...mentioning
confidence: 99%
“…Among them, nanomedicine has achieved tremendous progress in cancer management [12][13][14]. Nanoparticles can protect the cargo from degradation and facilitate their accumulation at tumor sites through passive diffusion or active targeting, optimizing the drug biodistribution [15][16][17][18][19]. Especially in the past few years, nanocarriers that can respond to biological cues in the tumor microenvironment (TME) attracted increasing attention [20][21][22].…”
Section: Introductionmentioning
confidence: 99%